Psoriasis medication may improve heart disease in patients with the skin condition

Public Release: 5-Feb-2019
European Society of Cardiology

Anti-inflammatory biologic* drugs used to treat severe psoriasis have the potential to prevent heart disease in patients with the skin condition, according to research published today in Cardiovascular Research, a journal of the European Society of Cardiology (ESC). During one year of treatment, biologic therapy improved coronary artery plaque similar to the effect of a low-dose statin.

•••••